Robertson Stephens Wealth Management LLC Sells 40 Shares of Stryker Corporation $SYK

Robertson Stephens Wealth Management LLC lessened its position in shares of Stryker Corporation (NYSE:SYK) by 6.2% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 601 shares of the medical technology company’s stock after selling 40 shares during the period. Robertson Stephens Wealth Management LLC’s holdings in Stryker were worth $238,000 at the end of the most recent quarter.

A number of other institutional investors also recently made changes to their positions in the company. Cascade Investment Group Inc. boosted its holdings in shares of Stryker by 6.3% during the second quarter. Cascade Investment Group Inc. now owns 588 shares of the medical technology company’s stock worth $233,000 after acquiring an additional 35 shares during the period. L. Roy Papp & Associates LLP boosted its holdings in shares of Stryker by 1.2% during the second quarter. L. Roy Papp & Associates LLP now owns 62,910 shares of the medical technology company’s stock worth $24,889,000 after acquiring an additional 726 shares during the period. Baskin Financial Services Inc. boosted its holdings in shares of Stryker by 0.6% during the second quarter. Baskin Financial Services Inc. now owns 112,795 shares of the medical technology company’s stock worth $44,625,000 after acquiring an additional 674 shares during the period. Commerzbank Aktiengesellschaft FI boosted its holdings in shares of Stryker by 0.3% during the second quarter. Commerzbank Aktiengesellschaft FI now owns 60,899 shares of the medical technology company’s stock worth $24,093,000 after acquiring an additional 160 shares during the period. Finally, Coordinated Financial Services Inc. bought a new stake in shares of Stryker in the second quarter valued at approximately $751,000. Institutional investors own 77.09% of the company’s stock.

Insider Activity at Stryker

In other news, Director Ronda E. Stryker sold 200,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 6th. The shares were sold at an average price of $376.45, for a total transaction of $75,290,000.00. Following the completion of the sale, the director owned 3,222,108 shares in the company, valued at $1,212,962,556.60. This trade represents a 5.84% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Viju Menon sold 500 shares of the firm’s stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $390.61, for a total transaction of $195,305.00. Following the sale, the insider owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. The trade was a 3.84% decrease in their position. The disclosure for this sale can be found here. Company insiders own 5.90% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently issued reports on the company. Truist Financial set a $415.00 price target on Stryker and gave the company a “hold” rating in a research note on Monday, August 4th. Redburn Partners set a $420.00 price target on shares of Stryker in a report on Thursday, September 18th. Wells Fargo & Company increased their price objective on Stryker from $435.00 to $445.00 and gave the company an “overweight” rating in a report on Friday, August 1st. Weiss Ratings restated a “buy (b-)” rating on shares of Stryker in a report on Wednesday, October 8th. Finally, Rothschild & Co Redburn started coverage on Stryker in a report on Thursday, September 18th. They set a “neutral” rating and a $420.00 price target for the company. Fifteen investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. Based on data from MarketBeat.com, Stryker currently has an average rating of “Moderate Buy” and a consensus price target of $430.10.

Stryker Price Performance

Shares of NYSE SYK opened at $364.77 on Monday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.06 and a current ratio of 1.78. The stock has a market cap of $139.45 billion, a price-to-earnings ratio of 48.31, a PEG ratio of 2.63 and a beta of 0.94. Stryker Corporation has a fifty-two week low of $329.16 and a fifty-two week high of $406.19. The firm’s 50-day simple moving average is $380.25 and its 200 day simple moving average is $378.90.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 31st. The medical technology company reported $3.13 EPS for the quarter, beating the consensus estimate of $3.07 by $0.06. The firm had revenue of $6.02 billion during the quarter, compared to analyst estimates of $5.92 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company’s revenue for the quarter was up 11.1% on a year-over-year basis. During the same quarter last year, the business posted $2.81 EPS. Stryker has set its FY 2025 guidance at 13.400-13.600 EPS. As a group, research analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Tuesday, September 30th will be paid a dividend of $0.84 per share. The ex-dividend date is Tuesday, September 30th. This represents a $3.36 annualized dividend and a dividend yield of 0.9%. Stryker’s dividend payout ratio (DPR) is presently 44.50%.

Stryker Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.